$ISRG
INTUITIVE SURGICAL INC

2013 Q2 Form 10-Q Financial Statement

#000119312513297410 Filed on July 22, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $578.5M $536.5M
YoY Change 7.83% 26.03%
Cost Of Revenue $173.3M $150.1M
YoY Change 15.46% 26.03%
Gross Profit $405.2M $386.4M
YoY Change 4.87% 26.03%
Gross Profit Margin 70.04% 72.02%
Selling, General & Admin $145.5M $120.9M
YoY Change 20.35% 13.52%
% of Gross Profit 35.91% 31.29%
Research & Development $41.20M $40.20M
YoY Change 2.49% 25.63%
% of Gross Profit 10.17% 10.4%
Depreciation & Amortization $16.60M $13.90M
YoY Change 19.42% 24.11%
% of Gross Profit 4.1% 3.6%
Operating Expenses $186.7M $161.1M
YoY Change 15.89% 16.32%
Operating Profit $218.5M $225.3M
YoY Change -3.02% 34.03%
Interest Expense $4.300M $4.000M
YoY Change 7.5% -2.44%
% of Operating Profit 1.97% 1.78%
Other Income/Expense, Net $4.300M $4.000M
YoY Change 7.5% -2.44%
Pretax Income $222.8M $229.3M
YoY Change -2.83% 33.16%
Income Tax $63.70M $74.40M
% Of Pretax Income 28.59% 32.45%
Net Earnings $159.1M $154.9M
YoY Change 2.71% 31.94%
Net Earnings / Revenue 27.5% 28.87%
Basic Earnings Per Share $3.99 $3.88
Diluted Earnings Per Share $3.90 $3.75
COMMON SHARES
Basic Shares Outstanding 39.90M shares 39.90M shares
Diluted Shares Outstanding 40.80M shares 41.30M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.290B $1.213B
YoY Change 6.35% 22.03%
Cash & Equivalents $432.7M $484.4M
Short-Term Investments $858.0M $728.0M
Other Short-Term Assets $43.00M $48.00M
YoY Change -10.42% 128.57%
Inventory $169.3M $119.4M
Prepaid Expenses
Receivables $358.6M $323.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.861B $1.703B
YoY Change 9.26% 24.78%
LONG-TERM ASSETS
Property, Plant & Equipment $267.6M $216.1M
YoY Change 23.83% 11.39%
Goodwill $137.4M $138.1M
YoY Change -0.51%
Intangibles
YoY Change
Long-Term Investments $1.737B $1.419B
YoY Change 22.41% 71.38%
Other Assets $106.0M $75.00M
YoY Change 41.33% -2.6%
Total Long-Term Assets $2.340B $1.923B
YoY Change 21.71% 49.63%
TOTAL ASSETS
Total Short-Term Assets $1.861B $1.703B
Total Long-Term Assets $2.340B $1.923B
Total Assets $4.201B $3.626B
YoY Change 15.86% 36.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $67.20M $54.60M
YoY Change 23.08% 43.68%
Accrued Expenses $127.0M $124.0M
YoY Change 2.42% 21.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $390.9M $346.8M
YoY Change 12.72% 26.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $91.60M $96.90M
YoY Change -5.47% 11.38%
Total Long-Term Liabilities $91.60M $96.90M
YoY Change -5.47% 11.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $390.9M $346.8M
Total Long-Term Liabilities $91.60M $96.90M
Total Liabilities $482.5M $443.7M
YoY Change 8.74% 22.91%
SHAREHOLDERS EQUITY
Retained Earnings $1.293B $1.186B
YoY Change 9.03%
Common Stock $2.428B $1.993B
YoY Change 21.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.719B $3.182B
YoY Change
Total Liabilities & Shareholders Equity $4.201B $3.626B
YoY Change 15.86% 36.83%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income $159.1M $154.9M
YoY Change 2.71% 31.94%
Depreciation, Depletion And Amortization $16.60M $13.90M
YoY Change 19.42% 24.11%
Cash From Operating Activities $189.1M $210.8M
YoY Change -10.29% 4.93%
INVESTING ACTIVITIES
Capital Expenditures -$25.00M -$8.100M
YoY Change 208.64% -78.96%
Acquisitions
YoY Change
Other Investing Activities $82.00M -$108.8M
YoY Change -175.37% -18.5%
Cash From Investing Activities $57.00M -$116.9M
YoY Change -148.76% -32.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $269.6M $15.20M
YoY Change 1673.68% -89.07%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -241.0M 64.90M
YoY Change -471.34% -167.11%
NET CHANGE
Cash From Operating Activities 189.1M 210.8M
Cash From Investing Activities 57.00M -116.9M
Cash From Financing Activities -241.0M 64.90M
Net Change In Cash 5.100M 158.8M
YoY Change -96.79% -334.22%
FREE CASH FLOW
Cash From Operating Activities $189.1M $210.8M
Capital Expenditures -$25.00M -$8.100M
Free Cash Flow $214.1M $218.9M
YoY Change -2.19% -8.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q3 isrg Time Limit Given To Plaintiffs For Filling Amended Complaint
TimeLimitGivenToPlaintiffsForFillingAmendedComplaint
30 D
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
39709905 shares
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
100000
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1500000
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2200000
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
-800000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
484400000
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3600000
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
3300000
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
300000
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8100000
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
7300000
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
800000
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
33400000
CY2013Q2 us-gaap Goodwill
Goodwill
137400000
CY2013Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
9500000
CY2013Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
57000000
CY2013Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1228800000
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2428000000
CY2013Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6400000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2700000 shares
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
3718800000
CY2013Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
3030400000
CY2013Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1737000000
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
50200000
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
100000
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
3027200000
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
70000000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
292.39
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39700000 shares
CY2013Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
97900000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
2600000 shares
CY2013Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
857500000
CY2013Q2 us-gaap Liabilities
Liabilities
482500000
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
67200000
CY2013Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
1734000000
CY2013Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
102200000
CY2013Q2 us-gaap Notional Amount Of Foreign Currency Cash Flow Hedge Derivatives
NotionalAmountOfForeignCurrencyCashFlowHedgeDerivatives
67000000
CY2013Q2 us-gaap Notional Amount Of Foreign Currency Cash Flow Hedge Derivatives
NotionalAmountOfForeignCurrencyCashFlowHedgeDerivatives
2700000000
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
196700000
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
91600000
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000 shares
CY2013Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1227000000
CY2013Q2 us-gaap Derivative Assets
DerivativeAssets
1900000
CY2013Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
106200000
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1292900000
CY2013Q2 us-gaap Assets
Assets
4201300000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
377.59
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
358600000
CY2013Q2 us-gaap Inventory Net
InventoryNet
169300000
CY2013Q2 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
5600000
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4201300000
CY2013Q2 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
4300000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
432700000
CY2013Q2 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
8800000
CY2013Q2 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
2969000000
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2100000
CY2013Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
100000
CY2013Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1729600000
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
390900000
CY2013Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
112700000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5100000 shares
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-2800000
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
600000
CY2013Q2 us-gaap Assets Current
AssetsCurrent
1861000000
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
267600000
CY2013Q2 isrg Available For Sale Securities Debt Maturities After Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue
7400000
CY2013Q2 isrg Available For Sale Securities Debt Maturities After Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost
8000000
CY2013Q2 isrg Share Based Compensation Arrangement By Share Based Payment Award Options Additional Shares Authorized Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalSharesAuthorizedWeightedAverageExercisePrice
CY2013Q2 isrg Intangible And Other Assets
IntangibleAndOtherAssets
92100000
CY2013Q2 isrg Available For Sale Securities Debt Maturities Fair Value Total
AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal
2965800000
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-200000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
465800000
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
900000
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1100000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
67300000
CY2012Q4 us-gaap Goodwill
Goodwill
138100000
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
9300000
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
54300000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2240100000
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4400000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
3580100000
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
2911500000
CY2012Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1596100000
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
41200000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
400000
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
2920500000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
104000000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40200000 shares
CY2012Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
83800000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1700000 shares
CY2012Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
770700000
CY2012Q4 us-gaap Liabilities
Liabilities
479100000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
57600000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
88000000
CY2012Q4 us-gaap Notional Amount Of Foreign Currency Cash Flow Hedge Derivatives
NotionalAmountOfForeignCurrencyCashFlowHedgeDerivatives
4400000000
CY2012Q4 us-gaap Notional Amount Of Foreign Currency Cash Flow Hedge Derivatives
NotionalAmountOfForeignCurrencyCashFlowHedgeDerivatives
20000000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
185700000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
77500000
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000 shares
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
87000000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1333400000
CY2012Q4 us-gaap Assets
Assets
4059200000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
340.83
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
370300000
CY2012Q4 us-gaap Inventory Net
InventoryNet
121500000
CY2012Q4 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
10200000
CY2012Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
3200000
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4059200000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
553700000
CY2012Q4 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
1200000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6600000
CY2012Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2700000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
401600000
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
75900000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4800000 shares
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
6200000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Assets Current
AssetsCurrent
1892800000
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
241800000
CY2012Q4 isrg Intangible And Other Assets
IntangibleAndOtherAssets
103400000
dei Trading Symbol
TradingSymbol
ISRG
dei Entity Registrant Name
EntityRegistrantName
INTUITIVE SURGICAL INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0001035267
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
35500000
us-gaap Operating Income Loss
OperatingIncomeLoss
469700000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
24600000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
997400000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9700000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
441100000
us-gaap Cost Of Services
CostOfServices
63200000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
447.18
us-gaap Share Based Compensation
ShareBasedCompensation
76900000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
554.50
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.47
us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
7500000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
41700000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
400000 shares
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
600000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
415400000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
100000 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.272 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
447100000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-291000000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-9300000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax
-1000000
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
1600000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
256.00
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-121000000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-34000000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
100000 shares
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
112100000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidationNetOfTax
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-16100000
us-gaap Loss Contingency Number Of Plaintiffs
LossContingencyNumberOfPlaintiffs
33 Plaintiff
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41100000 shares
us-gaap Sales Revenue Net
SalesRevenueNet
1189900000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11700000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-300000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
478300000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8700000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.68
us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 18px; TEXT-INDENT: 0px; LETTER-SPACING: normal; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> <font style="FONT-FAMILY: 'Times New Roman'" size="2"><b>NOTE 1. DESCRIPTION OF BUSINESS</b></font></p> <p style="PADDING-BOTTOM: 0px; TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 0px; LETTER-SPACING: normal; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> <font style="FONT-FAMILY: 'Times New Roman'" size="2">Intuitive designs, manufactures and markets&#xA0;<i>da Vinci</i><font style="FONT-FAMILY: 'Times New Roman'" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">&#xAE;</sup></font>&#xA0;Surgical Systems and related instruments and accessories, which taken together, are advanced surgical systems that the Company considers a new generation of surgery. This new generation of surgery, which the Company calls&#xA0;<i>da Vinci&#xA0;</i>surgery, combines the benefits of minimally invasive surgery (&#x201C;MIS&#x201D;) for patients with the ease of use, precision and dexterity of open surgery. A&#xA0;<i>da Vinci</i>&#xA0;Surgical System consists of a surgeon&#x2019;s console, a patient-side cart and a high performance vision system. The&#xA0;<i>da Vinci</i>&#xA0;Surgical System translates a surgeon&#x2019;s natural hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions, or ports. The&#xA0;<i>da Vinci</i>&#xA0;Surgical System is designed to provide its operating surgeons with intuitive control, range of motion, fine tissue manipulation capability and Three Dimensional (&#x201C;3-D&#x201D;), High-Definition (&#x201C;HD&#x201D;) vision while simultaneously allowing surgeons to work through the small ports enabled by MIS procedures.</font></p> </div>
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-300000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
82800000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-276800000
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
14200000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
300000
us-gaap Cost Of Revenue
CostOfRevenue
350400000
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
800000 shares
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
52300000
us-gaap Operating Expenses
OperatingExpenses
369800000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
26500000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40100000 shares
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
53200000
us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
900000000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1000000 shares
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
800000 shares
us-gaap Cost Of Goods Sold
CostOfGoodsSold
287200000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
192500000
us-gaap Depreciation
Depreciation
21300000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
947600000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
76900000
us-gaap Gross Profit
GrossProfit
839500000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
257200000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-20200000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-15700000
us-gaap Tax Benefit From Stock Options Exercised1
TaxBenefitFromStockOptionsExercised1
25800000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1900000 shares
us-gaap Net Income Loss
NetIncomeLoss
348000000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8600000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
26500000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1300000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
287000000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
800000 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
130300000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-300000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
339300000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11300000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-9000000
isrg Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant Additional Shares Authorized In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantAdditionalSharesAuthorizedInPeriod
shares
isrg Average Purchase Price Of Share Under Repurchase Program
AveragePurchasePriceOfShareUnderRepurchaseProgram
491280000
isrg Options Authorized Shares Available For Grant
OptionsAuthorizedSharesAvailableForGrant
1600000 shares
isrg Other Comprehensive Income Loss Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax
-8000000
isrg Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
700000
isrg Unrecognized Tax Benefits Increase In Accrued Interest
UnrecognizedTaxBenefitsIncreaseInAccruedInterest
1100000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
14900000
us-gaap Operating Income Loss
OperatingIncomeLoss
418600000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
21100000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
867500000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5400000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
324800000
us-gaap Share Based Compensation
ShareBasedCompensation
67700000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.26
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
56400000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
300000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
15200000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.300 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
375800000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-525100000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
2000000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax
-400000
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
700000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
18600000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-8400000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
138500000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidationNetOfTax
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4400000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41100000 shares
us-gaap Sales Revenue Net
SalesRevenueNet
1031700000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
21900000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
200000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
426400000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2700000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.52
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
200000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
78600000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
168000000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
200000
us-gaap Cost Of Revenue
CostOfRevenue
289400000
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
100000 shares
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
46600000
us-gaap Operating Expenses
OperatingExpenses
323700000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
44700000
us-gaap Cost Of Services
CostOfServices
54800000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39700000 shares
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12200000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1400000 shares
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
us-gaap Cost Of Goods Sold
CostOfGoodsSold
234600000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
164200000
us-gaap Depreciation
Depreciation
15200000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1022900000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
67700000
us-gaap Gross Profit
GrossProfit
742300000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
229400000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-15200000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6100000
us-gaap Tax Benefit From Stock Options Exercised1
TaxBenefitFromStockOptionsExercised1
44700000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000 shares
us-gaap Net Income Loss
NetIncomeLoss
298400000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7800000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
44700000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-600000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
245100000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
128000000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-100000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
301100000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12000000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2200000
isrg Average Purchase Price Of Share Under Repurchase Program
AveragePurchasePriceOfShareUnderRepurchaseProgram
523060000
isrg Income Tax Reconciliation Benefit For Unrecognized Tax Benefits
IncomeTaxReconciliationBenefitForUnrecognizedTaxBenefits
8500000
isrg Other Comprehensive Income Loss Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax
2900000
isrg Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
200000
CY2013Q1 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
1000000000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
225300000
CY2012Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
10100000
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
453100000
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.75
CY2012Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
1100000
CY2012Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
15200000
CY2012Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.324 pure
CY2012Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
1100000
CY2012Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax
-700000
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
1800000
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidationNetOfTax
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41300000 shares
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
536500000
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-100000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
229300000
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2100000
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.88
CY2012Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-100000
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
40200000
CY2012Q2 us-gaap Cost Of Revenue
CostOfRevenue
150100000
CY2012Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
100000 shares
CY2012Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
23200000
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
161100000
CY2012Q2 us-gaap Cost Of Services
CostOfServices
27200000
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39900000 shares
CY2012Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1400000 shares
CY2012Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
122900000
CY2012Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
83400000
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33300000
CY2012Q2 us-gaap Gross Profit
GrossProfit
386400000
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
700000 shares
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
154900000
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4000000
CY2012Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1100000
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
120900000
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
74400000
CY2012Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
157000000
CY2012Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1100000
CY2012Q2 isrg Average Purchase Price Of Share Under Repurchase Program
AveragePurchasePriceOfShareUnderRepurchaseProgram
523060000
CY2012Q2 isrg Other Comprehensive Income Loss Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax
2800000
CY2012Q2 isrg Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
700000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
218500000
CY2013Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
12400000
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
480400000
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.90
CY2013Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-200000
CY2013Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
269600000
CY2013Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.286 pure
CY2013Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-10200000
CY2013Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax
-400000
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
200000
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidationNetOfTax
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40800000 shares
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
578500000
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
100000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
222800000
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10200000
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.99
CY2013Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
100000
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41200000
CY2013Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
100000
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
173300000
CY2013Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
500000 shares
CY2013Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
26300000
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
186700000
CY2013Q2 us-gaap Cost Of Services
CostOfServices
32400000
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39900000 shares
CY2013Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
900000 shares
CY2013Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
140900000
CY2013Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
98100000
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
38700000
CY2013Q2 us-gaap Gross Profit
GrossProfit
405200000
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2100000 shares
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
159100000
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4300000
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
145500000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63700000
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
148900000
CY2013Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-10100000
CY2013Q2 isrg Average Purchase Price Of Share Under Repurchase Program
AveragePurchasePriceOfShareUnderRepurchaseProgram
493490000
CY2013Q2 isrg Other Comprehensive Income Loss Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax
-9900000
CY2013Q2 isrg Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
300000

Files In Submission

Name View Source Status
0001193125-13-297410-index-headers.html Edgar Link pending
0001193125-13-297410-index.html Edgar Link pending
0001193125-13-297410.txt Edgar Link pending
0001193125-13-297410-xbrl.zip Edgar Link pending
d551118d10q.htm Edgar Link pending
d551118dex311.htm Edgar Link pending
d551118dex312.htm Edgar Link pending
d551118dex321.htm Edgar Link pending
d551118dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
isrg-20130630.xml Edgar Link completed
isrg-20130630.xsd Edgar Link pending
isrg-20130630_cal.xml Edgar Link unprocessable
isrg-20130630_def.xml Edgar Link unprocessable
isrg-20130630_lab.xml Edgar Link unprocessable
isrg-20130630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending